Myocardial contrast echocardiography in the evaluation of viable myocardium after acute myocardial infarction

American Journal of Cardiology

Volumn 81, Issue 12 A, 1998, Pages 29G-32G

  Galiuto, Leonarda ^b   Iliceto, Sabino ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CONFERENCE PAPER; CONTRAST ECHOCARDIOGRAPHY; DIAGNOSTIC VALUE; FIBRINOLYTIC THERAPY; HEART MUSCLE CONTRACTILE FORCE; HEART PERFORMANCE; HUMAN; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

EID: 0032543635     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00050-2     Document Type: Conference Paper

References (33)

1. Reimer KA, Jenning RB, The "wavefront phenomenon" of myocardial cell death. Lab Invest 1979;40:633-644.
2. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-1705.
3. Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation 1992;85:2080-2089.
4. Galiuto L, Marchese A, Cavallari D, Amico A, Napoli VF, Iliceto S, Rizzon P. Myocardial viability assessed by dobutamine echocardiography soon after myocardial infarction: influence of myocardial echocontrast opacification of infarcted area and TIMI grading of infarcted related artery. (Abstr.) J Am Coll Cardiol 1994;(suppl I):I-360A.
5. Kloner RA, Przyklenk K, Patel B. Alterated myocardial states: the stunned and hibernating myocardium. Am J Med 1989;86(suppl 1A):14S-22S.
6. Pierard LA, De Landsheere C, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-1031.
7. Barilla R, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-1531.
8. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, Bourdillon PD, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of myocardial infarction. Circulation 1993;88:405-415.
9. Iliceto S, Galiuto L, Marchese A, Cavallari D, Colonna P, Biasco G, Rizzon P. Microvascular integrity, contractile reserve and myocardial viability after acute myocardial infarction. Am J Cardiol 1996;77:441-445.
10. Sklenar J, Ismail S, Villanueva FS, Goodman C, Glasheen WP, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: an experimental evaluation. Circulation 1994;90:1502-1512.
11. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-1831.
12. Bolognese L, Antoniucci D, Rovai D, Buonamici G, Cerisano G, Santoro GM, Marini C, L'Abbate A, Fazzini PF. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996;28:1677-1683.
13. Nagueh AF, Vaduganathan P, Ali N, Blaustein A, Verani MS, Winters WL, Zoghbi WA. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29:985-993.
14. Shaper W, Frenzel H, Hort W. Experimental coronary artery occlusion. I. Measurement of infarct size. Basic Res Cardiol 1979;74:46-53.
15. Heyndrickx GR, Amano J, Patrick TA, Manders WT, Rogers GG, Rosendorff C, Vatner SF. Effects of coronary artery reperfusion on regional myocardial blood flow and function in conscious baboons. Circulation 1985;71:1029-1037.
16. Widimsky P, Cornel JH, Ten Cate FJ. Evaluation of collateral blood flow by myocardial contrast enhanced echocardiography. Br Heart J 1988;59:20-22.
17. Grill HP, Brinker JA, Tanbe JC, Walford GD, Midei MG, Flaherty JT, Weiss JL. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty. J Am Coll Cardiol 1990;16:1594-1600.
18. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
19. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure, and myocardial damage. Circulation 1983;68(suppl I):8-15.
20. The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbility and infarct size at 21 days. N Engl J Med 1986;314:1465-1471.
21. Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S, Rozeman Y, Lotan C, Mosseri M, Sapoznikov D, Luria MH, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985;313:1384-1389.
22. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B. The effect of thrombolytic therapy on left ventricular function: a report on r-PA and streptokinase from the TIMI Phase I trial. Circulation 1987;75:817-829.
23. Serruys PW, Simoon ML, Suryapranata H, Vermeer F, Wijns W, van den Brand M, Bär F, Zwaan C, Krauss XH, Remme WJ, et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1986;7:729-742.
24. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 1977;9:605-616.
25. Bernier M, Hearse DJ, Manning AS. Reperfusion induced arrhythmias and oxygen-derived free radicals: studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986; 58:331-340.
26. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol 1988;12:239-249.
27. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword. J Clin Invest 1985;76:1713-1719.
28. Kloner RA, Ganote CE, Jennings RB. The "no reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
29. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1846-1861.
30. Jeremy RW, Links JM, Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with Positron Emission Tomography. J Am Coll Cardiol 1990;16:695-704.
31. Ben Johnson W, Malone SA, Pantely GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988;78:462-472.
32. Piana RA, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994;89:2514-2518.
33. Porter T, Li S, Deligonul U, Oster R. Detection of no-reflow zones using intravenous ultrasound contrast and intermittent harmonic imaging in patients with acute myocardial infarction and angiographically successful recanalization (Abstr.). J Am Soc Echocardiogr 1997;10:413A.